Global Herpes Zoster Treatment Market Growth (Status and Outlook) 2019-2024
Table of Contents
2019-2024 Global Herpes Zoster Treatment Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Herpes Zoster Treatment Market Size 2014-2024
- 2.1.2 Herpes Zoster Treatment Market Size CAGR by Region
- 2.2 Herpes Zoster Treatment Segment by Type
- 2.2.1 Oral
- 2.2.2 Topical
- 2.2.3 Others
- 2.3 Herpes Zoster Treatment Market Size by Type
- 2.3.1 Global Herpes Zoster Treatment Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Herpes Zoster Treatment Market Size Growth Rate by Type (2014-2019)
- 2.4 Herpes Zoster Treatment Segment by Application
- 2.4.1 Hospitals
- 2.4.2 Clinics
- 2.4.3 Home Care Settings
- 2.5 Herpes Zoster Treatment Market Size by Application
- 2.5.1 Global Herpes Zoster Treatment Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Herpes Zoster Treatment Market Size Growth Rate by Application (2014-2019)
3 Global Herpes Zoster Treatment by Players
- 3.1 Global Herpes Zoster Treatment Market Size Market Share by Players
- 3.1.1 Global Herpes Zoster Treatment Market Size by Players (2017-2019)
- 3.1.2 Global Herpes Zoster Treatment Market Size Market Share by Players (2017-2019)
- 3.2 Global Herpes Zoster Treatment Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Herpes Zoster Treatment by Regions
- 4.1 Herpes Zoster Treatment Market Size by Regions
- 4.2 Americas Herpes Zoster Treatment Market Size Growth
- 4.3 APAC Herpes Zoster Treatment Market Size Growth
- 4.4 Europe Herpes Zoster Treatment Market Size Growth
- 4.5 Middle East & Africa Herpes Zoster Treatment Market Size Growth
5 Americas
- 5.1 Americas Herpes Zoster Treatment Market Size by Countries
- 5.2 Americas Herpes Zoster Treatment Market Size by Type
- 5.3 Americas Herpes Zoster Treatment Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Herpes Zoster Treatment Market Size by Countries
- 6.2 APAC Herpes Zoster Treatment Market Size by Type
- 6.3 APAC Herpes Zoster Treatment Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Herpes Zoster Treatment by Countries
- 7.2 Europe Herpes Zoster Treatment Market Size by Type
- 7.3 Europe Herpes Zoster Treatment Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Herpes Zoster Treatment by Countries
- 8.2 Middle East & Africa Herpes Zoster Treatment Market Size by Type
- 8.3 Middle East & Africa Herpes Zoster Treatment Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Herpes Zoster Treatment Market Forecast
- 10.1 Global Herpes Zoster Treatment Market Size Forecast (2019-2024)
- 10.2 Global Herpes Zoster Treatment Forecast by Regions
- 10.2.1 Global Herpes Zoster Treatment Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Herpes Zoster Treatment Forecast by Type
- 10.8 Global Herpes Zoster Treatment Forecast by Application
11 Key Players Analysis
- 11.1 Roche
- 11.1.1 Company Details
- 11.1.2 Herpes Zoster Treatment Product Offered
- 11.1.3 Roche Herpes Zoster Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Roche News
- 11.2 Novartis
- 11.2.1 Company Details
- 11.2.2 Herpes Zoster Treatment Product Offered
- 11.2.3 Novartis Herpes Zoster Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 Novartis News
- 11.3 Merck
- 11.3.1 Company Details
- 11.3.2 Herpes Zoster Treatment Product Offered
- 11.3.3 Merck Herpes Zoster Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 Merck News
- 11.4 GlaxoSmithKline
- 11.4.1 Company Details
- 11.4.2 Herpes Zoster Treatment Product Offered
- 11.4.3 GlaxoSmithKline Herpes Zoster Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 GlaxoSmithKline News
- 11.5 Abbott Laboratories
- 11.5.1 Company Details
- 11.5.2 Herpes Zoster Treatment Product Offered
- 11.5.3 Abbott Laboratories Herpes Zoster Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Abbott Laboratories News
- 11.6 Astellas Pharma
- 11.6.1 Company Details
- 11.6.2 Herpes Zoster Treatment Product Offered
- 11.6.3 Astellas Pharma Herpes Zoster Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Astellas Pharma News
- 11.7 Bausch Health Companies
- 11.7.1 Company Details
- 11.7.2 Herpes Zoster Treatment Product Offered
- 11.7.3 Bausch Health Companies Herpes Zoster Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Bausch Health Companies News
- 11.8 Teva Pharmaceutical
- 11.8.1 Company Details
- 11.8.2 Herpes Zoster Treatment Product Offered
- 11.8.3 Teva Pharmaceutical Herpes Zoster Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 Teva Pharmaceutical News
- 11.9 Foamix Pharmaceuticals
- 11.9.1 Company Details
- 11.9.2 Herpes Zoster Treatment Product Offered
- 11.9.3 Foamix Pharmaceuticals Herpes Zoster Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 Foamix Pharmaceuticals News
12 Research Findings and Conclusion
Herpes Zoster, also known as zoster or shingles, is a viral disease characterized by a painful skin rash with blisters in a localized area. Typically the rash occurs in a single, wide stripe either on the left or right side of the body or face. Two to four days before the rash occurs there may be tingling or local pain in the area. Otherwise there are typically few symptoms though some may have fever, headache, or feel tired. The rash usually heals within two to four weeks; however, some people develop ongoing nerve pain which can last for months or years, a condition called postherpetic neuralgia (PHN). In those with poor immune function the rash may occur widely. If the rash involves the eye, vision loss may occur.
According to this study, over the next five years the Herpes Zoster Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Herpes Zoster Treatment business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Herpes Zoster Treatment market by product type, application, key companies and key regions.
This study considers the Herpes Zoster Treatment value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Oral
Topical
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospitals
Clinics
Home Care Settings
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Roche
Novartis
Merck
GlaxoSmithKline
Abbott Laboratories
Astellas Pharma
Bausch Health Companies
Teva Pharmaceutical
Foamix Pharmaceuticals
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Herpes Zoster Treatment market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Herpes Zoster Treatment market by identifying its various subsegments.
Focuses on the key global Herpes Zoster Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Herpes Zoster Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Herpes Zoster Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.